Back to Search
Start Over
Adaptive NK Cells Resist Regulatory T-cell Suppression Driven by IL37.
- Source :
-
Cancer immunology research [Cancer Immunol Res] 2018 Jul; Vol. 6 (7), pp. 766-775. Date of Electronic Publication: 2018 May 21. - Publication Year :
- 2018
-
Abstract
- Natural killer (NK) cells are capable of fighting viral infections and cancer. However, these responses are inhibited by immune suppressor cells in the tumor microenvironment. Tumor progression promotes the recruitment and generation of intratumoral regulatory T cells (Treg), associated with a poor prognosis in cancer patients. Here, we show that canonical NK cells are highly susceptible to Treg-mediated suppression, in contrast to highly resistant CD57 <superscript>+</superscript> FcεRγ <superscript>-</superscript> NKG2C <superscript>+</superscript> adaptive (CD56 <superscript>+</superscript> CD3 <superscript>-</superscript> ) NK cells that expand in cytomegalovirus exposed individuals. Specifically, Tregs suppressed canonical but not adaptive NK-cell proliferation, IFNγ production, degranulation, and cytotoxicity. Treg-mediated suppression was associated with canonical NK-cell downregulation of TIM3, a receptor that activates NK-cell IFNγ production upon ligand engagement, and upregulation of the NK-cell inhibitory receptors PD-1 and the IL1 receptor family member, IL1R8 (SIGIRR or TIR8). Treg production of the IL1R8 ligand, IL37, contributed to the phenotypic changes and diminished function in Treg-suppressed canonical NK cells. Blocking PD-1, IL1R8, or IL37 abrogated Treg suppression of canonical NK cells while maintaining NK-cell TIM3 expression. Our data uncover new mechanisms of Treg-mediated suppression of canonical NK cells and identify that adaptive NK cells are inherently resistant to Treg suppression. Strategies to enhance the frequency of adaptive NK cells in the tumor microenvironment or to blunt Treg suppression of canonical NK cells will enhance the efficacy of NK-cell cancer immunotherapy. Cancer Immunol Res; 6(7); 766-75. ©2018 AACR .<br /> (©2018 American Association for Cancer Research.)
- Subjects :
- Biomarkers
Cell Line, Tumor
Cytokines metabolism
Gene Expression
Hepatitis A Virus Cellular Receptor 2 genetics
Hepatitis A Virus Cellular Receptor 2 metabolism
Humans
Immunophenotyping
Lymphocyte Activation immunology
Programmed Cell Death 1 Receptor metabolism
Signal Transduction
Immunomodulation
Interleukin-1 metabolism
Killer Cells, Natural immunology
Killer Cells, Natural metabolism
T-Lymphocytes, Regulatory immunology
T-Lymphocytes, Regulatory metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 2326-6074
- Volume :
- 6
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Cancer immunology research
- Publication Type :
- Academic Journal
- Accession number :
- 29784636
- Full Text :
- https://doi.org/10.1158/2326-6066.CIR-17-0498